Novartis AG (NVSEF)
OTC
Closed
Aug 21, 2026
Day's Range
157.6152 wk Range
118.02Overview - NVSEF - Novartis AG
Key Statistics
Valuation
Enterprise Value
341.37B
P/E (Trailing)
‪23.80‬
PEG Ratio
‪-1.36‬
Price / Sales (TTM)
‪5.28‬
Price / Book
‪7.21‬
EV / EBITDA
‪14.77‬
Profitability
Gross Margin
‪75.18%‬
Profit Margin
‪22.50%‬
Operating Margin
‪34.62%‬
Return on Assets
‪10.25%‬
Return on Equity
‪30.35%‬
Ownership
Shares Outstanding
1.90B
Float
1.85B
Held by Insiders
‪2.11%‬
Held by Institutions
‪45.89%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪152.78‬
200-Day Avg
‪146.71‬
Dividends
Payout Ratio
‪69.86%‬
Frequency
Annual
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NVSEF - Novartis AG
Peers - NVSEF - Novartis AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
- NVNVSEFOTCNovartis AG299.57BMarket Cap+19.55%52-week change23.81P/E (Trailing)‪22.50%‬Profit Margin
- RHHVFOTCRoche Holding AG372.60BMarket Cap+30.12%52-week change24.51P/E (Trailing)‪19.60%‬Profit Margin
- NONOFOTCNovo Nordisk A/S206.51BMarket Cap-22.13%52-week change11.50P/E (Trailing)‪35.34%‬Profit Margin
- GLAXFOTCGSK plc101.54BMarket Cap+21.50%52-week change15.94P/E (Trailing)‪14.52%‬Profit Margin
- CHGCYOTCChugai Pharmaceutical Co. Ltd.73.03BMarket Cap+4.25%52-week change23.88P/E (Trailing)‪35.10%‬Profit Margin
- BAYRYOTCBayer AG Sponsored ADR56.46BMarket Cap+43.63%52-week change28.38P/E (Trailing)‪-3.83%‬Profit Margin
- BAYZFOTCBayer AG53.65BMarket Cap+40.76%52-week change28.11P/E (Trailing)‪-3.83%‬Profit Margin
Profile Summary - NVSEF - Novartis AG
About
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, specializing in innovative medicines across multiple therapeutic areas including cardiovascular, immunology, neuroscience, oncology, and renal and metabolic diseases. The company operates through two primary divisions: Innovative…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
